A Novel Dual PI3K/mTOR Inhibitor, XIN-10, for the Treatment of Cancer

An imbalance in PI3K/AKT/mTOR pathway signaling in humans often leads to cancer. Therefore, the investigation of anti-cancer medications that inhibit PI3K and mTOR has emerged as a significant area of research. The aim of this study was to explore the effect of XIN-10, a dual PI3K/mTOR inhibitor, on...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Leixuan, Sun, Xin, Yang, Yang, Xia, Lulu, Wang, Shiyu, Fu, Yuxing, Zhu, Yuxuan, Xu, Shan, Zhu, Wufu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573424/
https://www.ncbi.nlm.nih.gov/pubmed/37834269
http://dx.doi.org/10.3390/ijms241914821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573424/
https://www.ncbi.nlm.nih.gov/pubmed/37834269
http://dx.doi.org/10.3390/ijms241914821

Ejemplares similares